Quantcast
Last updated on May 26, 2012 at 15:04 EDT

Texas Petrochemicals Reports Fiscal 2009 Second Quarter Results

February 17, 2009
Repost This

Second quarter results were affected by the aftermath of Hurricane Ike

and the impact of the economic recession

HOUSTON, Feb. 17 /PRNewswire-FirstCall/ – Texas Petrochemicals, Inc., (OTC: TXPI.PK) (“TPI”) today reported revenues of $410.0 million for the second quarter of fiscal 2009, a decrease of approximately $100.0 million from $509.9 million reported in the prior year second quarter. The overall decrease in revenues reflects the combined impact of significantly lower volumes driven by the aftermath of Hurricane Ike and the economic recession that led to a decline in commodity prices and a collapse in customer demand.

The Company has estimated the adverse impact of Hurricane Ike on second quarter Adjusted EBITDA to be substantial, and is preparing its claim to recover a portion of the loss under its business interruption insurance coverage. Despite the fact that the Company was able to restart all its plants by the end of the first fiscal quarter, its ability to receive raw materials and ship products continued to be significantly hampered as both suppliers’ and customers’ facilities were forced to take outages that have lasted up to several months.

Charlie Shaver, President and CEO, said, “At the start of the second fiscal quarter we continued to be affected by the aftermath of Hurricane Ike, which significantly affected several of our major customers and suppliers. Furthermore, the global economic crisis and its resulting impact on the chemical industry that led to widespread shutdowns and layoffs have created an unprecedented destruction of demand across all sectors of the industry.

“We have acted quickly in response to these challenging conditions to ensure that we maintain adequate liquidity and operational flexibility to respond to rapidly changing market conditions as we navigate our way through the next several quarters. I am pleased that our aggressive actions to align our current level of operations with demand have generated significant positive cash flow over the latter part of the second quarter and into the third quarter.

“We have funded necessary maintenance capital, but have delayed other discretionary spending and continue to tightly control our working capital. We are taking the necessary steps to manage through this challenging economic environment and are focused on serving our customers while operating responsibly in terms of our health, safety and environmental activities.”

Fiscal 2009 Second Quarter and Year-to-Date Results

  • Total sales volume for the fiscal 2009 second quarter was up 16% compared to the first quarter, but was down 26% versus the prior year second quarter. Year-to-date total sales volume was down 30% compared to the comparable fiscal 2008 period.

  • Total second quarter revenues were 25% lower than the immediately preceding quarter and 20% lower than the second quarter of the prior year. Year-to-date revenues were down 4% versus the comparable prior year period due to the impact of Hurricane Ike and the slowdown in demand in the second quarter.

  • Second quarter total Adjusted EBITDA (earnings before interest, taxes, depreciation, amortization and additional items), was a loss of $17.1 million compared to positive $18.3 million in the first quarter and $21.5 million in the prior year quarter. Year-to-date Adjusted EBITDA was $1.2 million versus $47.5 million in fiscal 2008. For additional information regarding Adjusted EBITDA (a non-GAAP financial measure), refer to the reconciliation table at the end of this press release.

  • As a result of the rapid and large declines in the selling prices of our products, we recorded during the second fiscal quarter a lower-of-cost-or-market adjustment to our inventory of $11.6 million, as of December 31, 2008. Excluding the impact of this write-down, second quarter Adjusted EBITDA would have been a loss of $5.5 million.

  • Net loss in the second quarter was $26.7 million, or $1.51 per diluted share, compared to net income of $1.4 million in the first quarter and $2.2 million in the second quarter last year. Six months year-to-date net loss was $25.3 million, or $1.43 per diluted share, versus positive $9.3 million, or $0.51 per diluted share, for the first six months of fiscal 2008.

  • Our second quarter results reflect unprecedented erosion in demand for our products as the impact of the global economic crisis worsened over the course of the quarter. In addition to the impact of the depressed economic conditions during the second quarter, demand was also negatively impacted by customer efforts to reduce year-end inventory levels and lingering effects of the September hurricanes as some customers continued to struggle to recover from related plant outages. As a result, we shut down several of our production facilities in early December to balance demand and inventory.

Highlights:

  • We have completed and successfully commissioned the new polyisobutylene (PIB) facility in Houston. The plant is now fully operational and is supplying a full range of PIB products to our customers. This project essentially completes our capital expansion program that was undertaken back in 2007.

  • We continue to pursue the process of SEC registration commenced in the second quarter. We anticipate being effective as an SEC registrant during the third fiscal quarter and will begin regular quarterly and annual reporting with the SEC beginning with our third fiscal quarter ended March 31, 2009.

  • Cost reduction efforts undertaken during the second quarter included, among other things, temporary shutdowns of our C4 facility at our Port Neches site and our Performance Products facilities at our Houston site, as well as reductions in both our plant contractor workforce and employee headcount across all functional areas. The Port Neches facility was down for the second half of December and the Houston-based Performance Products facilities were down for the entire month of December.

  • During January we experienced an incremental improvement in demand and more stable pricing for most of our products. As a result, all plants have successfully restarted and are now operating. The level of customer orders and indications of demand are continuing to show improvement.

Results of Operations

The financial statements and segment information provided at the end of this press release should be referred to when reading the discussion of our second quarter and year-to-date operating results provided below.

Second Quarter of Fiscal 2009 versus First Quarter of Fiscal 2009

Revenues

Total revenues for the second quarter of fiscal 2009 were $410.0 million, which were $133.3 million, or 25%, lower than the immediately preceding quarter revenues of $543.3 million. The overall decrease reflects lower revenues for the C4 Processing and Performance Products segments of $101.6 million and $40.7 million, respectively, partially offset by higher revenues from Other products of $9.0 million. Although second quarter sales volumes were moderately higher than the previous quarter for both segments, the primary driver behind the lower revenues was substantially lower average selling prices for all of our finished products. Overall sales volumes in the first and second quarter of fiscal 2009 were negatively impacted by events and circumstances which resulted in abnormally low volumes for both quarters. First quarter sales volumes were significantly curtailed due to the impacts of Hurricanes Gustav and Ike in September, which impeded our ability to ship product as well as our customers’ ability to take product. Second quarter sales volumes were negatively impacted by the aftermath of the September hurricanes and the unprecedented deterioration in demand and pricing over the course of the quarter as a result of the global economic crisis.

The $101.6 million, or 25%, decrease in revenues for the C4 Processing segment reflects a negative impact of $121 million due to significantly lower average selling prices, partially offset by a positive impact of 10% higher sales volume of $20 million.

The $40.7 million, or 32%, decrease in Performance Products segment revenues was likewise driven by significantly lower average selling prices in the second quarter. The negative impact of the lower selling prices was $52 million, while the positive impact of 11% higher sales volume was $12 million.

The higher second quarter revenues for Other products reflects higher sales volume of MTBE produced from crude C4 isobutylene. First quarter sales volume was curtailed due to the September hurricanes that impeded our ability to ship the product during the latter part of the first quarter.

Adjusted EBITDA

Total Adjusted EBITDA for the second quarter of fiscal 2009 was a loss of $17.1 million versus a positive $18.3 million for the first quarter. The overall decrease of $35.4 million consists primarily of declines for the C4 Processing segment of $29.4 million and the Performance Products segment of $6.7 million. Although most of our raw material supply and customer sales contracts provide linkage between the selling prices of our products and the cost of our raw materials, we are still exposed to inventory devaluation when selling prices decline between the time we purchase our raw materials and sell our finished products, which is what occurred over last part of the first quarter and throughout the second quarter. As a result of devaluation of our inventories, lower-of-cost-or-market adjustments were recorded as of September 30, 2008 and December 31, 2008 in the amounts of $9.4 million and $11.6 million, respectively.

The primary components of the C4 Products decline of $29.4 million are the negative impact of lower unit margins of $33 million and higher lower-of-cost-or-market adjustment of $2.8 million, partially offset by the positive impact of higher sales volumes of $3 million and lower operating expenses of $3.6 million.

The $6.7 million lower Adjusted EBITDA for the Performance Products segment was also due primarily to lower unit margins and higher lower-of-cost-or-market adjustment of $0.8 million, partially offset by higher volumes. The lower unit margins had a negative impact of $9 million and the higher sales volumes had a positive impact of $3 million.

Second Quarter of Fiscal 2009 versus Second Quarter of Fiscal 2008

Revenues

Fiscal 2009 second quarter revenues of $410.0 million were down 20% compared to prior year second quarter revenues of $509.9 million. The overall decrease reflects lower revenues for the C4 Processing and Performance Products segments of $67.7 million and $22.6 million, respectively, as well as the elimination of non-core MTBE business, which generated revenues of $23.6 million in the prior year quarter, partially offset by higher sales for Other products of $14.0 million. The driver behind the lower revenues in the fiscal 2009 second quarter versus the prior year quarter is 26% lower sales volumes, which reflects the carryover impact of the September 2008 hurricanes and the unprecedented erosion of economic and market conditions that occurred over the course of the fiscal 2009 second quarter. Overall average selling prices were comparable between the two quarters as moderately higher average prices for the C4 segment were offset by moderately lower average prices for the Performance Products segment.

The $67.7 million, or 18%, lower revenues for the C4 Processing segment reflects a negative $115 million impact of 31% lower sales volumes, partially offset by a positive impact of $47 million from higher average selling prices.

The $22.6 million, or 21%, decrease in Performance Products segment revenues reflects both lower sales volume and lower average prices, which negatively impacted the fiscal 2009 quarter by $12 million and $11 million, respectively.

The increase in Other product revenues primarily reflects sales of MTBE produced from crude C4 isobutylene in conjunction with the start-up of our isobutylene processing unit in second quarter of fiscal 2008. Sales of MTBE produced from crude C4 isobutylene have been reported as Other product sales since the third quarter of fiscal 2008.

Adjusted EBITDA

Fiscal 2009 second quarter Adjusted EBITDA loss of $17.1 million compares to Adjusted EBITDA of $21.5 million for the comparable prior year quarter. The overall decrease of $38.6 million consists primarily of declines for the C4 Processing segment of $33.3 million and the Performance Products segment of $2.8 million. As reported above, the fiscal 2009 quarter includes a lower-of-cost-or-market negative impact as of December 31, 2008 in the amount of $11.6 million, due primarily to the significant decline in butadiene selling prices over the latter part of the quarter.

The primary components of the C4 Products decline of $33.3 million were the negative impacts of lower volumes and lower unit margins of $14 million and $11 million, respectively, and a December 31, 2008 lower-of-cost-or-market adjustment of $8.6 million.

The $2.8 million lower Adjusted EBITDA for the Performance Products segment reflects a lower volume impact of $2 million and a December 31, 2008 lower-of-cost-or-market adjustment of $1.2 million, partially offset by the impact of slightly better unit margins.

First Six Months of Fiscal 2009 versus First Six Months of Fiscal 2008

Revenues

Total revenues for the first six months of fiscal 2009 were $953.3 million, a decrease of $42.7 million, or 4%, compared to total revenues of $996.0 million for the comparable period of fiscal 2008. The overall lower revenues reflects the elimination of MTBE revenues, which were $66.1 million in the prior year period, as well as a decline in C4 Processing segment revenues of $15.4 million, partially offset by higher revenues for the Performance Products segment and Other products of $18.8 million and $20.0 million, respectively. Combined fiscal 2009 sales volumes for the C4 Processing and Performance Products segments were down 27% compared to fiscal 2008, reflecting the negative impacts of the September 2008 hurricanes and the unprecedented erosion in demand that occurred over the course of the fiscal 2009 second quarter. In spite of a significant decline in selling prices during the fiscal 2009 second quarter, average selling prices for the first six months of fiscal 2009 were higher than the comparable prior year period as they were weighted by the high average selling prices from first quarter of fiscal 2009 that still reflected the impact of unprecedented high energy and gasoline prices as well as short supply of some of our products.

The $15.4 million, or 2%, decrease in revenues for the C4 Processing segment reflects the impact of 32% lower sales volumes, which was substantially offset by the impact of significantly higher average selling prices. The lower sales volume had a negative impact on revenues of $232 million and the higher average selling prices had a positive impact on revenues of $216 million.

The $18.8 million, or 10%, increase in Performance Products segment revenues consists of the positive impact of moderately higher average selling prices of $26 million, partially offset by the negative impact of 4% lower sales volumes of $8 million.

The higher Other product revenues of $20.0 million reflects sales of MTBE produced from crude C4 isobutylene in conjunction with the start-up of our isobutylene processing unit in second quarter of fiscal 2008. Beginning in third quarter of fiscal 2008, sales and cost of sales of MTBE produced from crude C4 isobutylene are included in Other products. Prior to third quarter of fiscal 2008, MTBE sales and cost of sales were reported in the MTBE segment and consists of MTBE produced by our Houston dehydrogenation units.

Adjusted EBITDA

Total Adjusted EBITDA for the first half of fiscal 2009 was $1.2 million compared to $47.5 million for the first half of fiscal 2008. Adjusted EBITDA for the C4 Processing segment and Other products were lower by $35.1 million and $10.0 million, respectively, and elimination of non-core MTBE business resulted in additional decrease of $6.2 million. Partially offsetting these negative items were a $2.4 million improvement for the Performance Products segment and lower corporate expenses of $2.6 million. Total lower-of-cost-or-market adjustments in the first half of fiscal 2009 were $21.0 million, of which $9.4 million was recorded as of September 30, 2008 and $11.6 million was recorded as of December 31, 2008.

The primary components of the C4 Products decline of $35.1 million are the negative impact of lower volumes of $27 million, higher operating expenses of $4.0 million and lower-of-cost-or-market adjustments of $14.4 million, partially offset by the impact of better unit margins of $10 million.

The $2.4 million higher Adjusted EBITDA for the Performance Products segment was due primarily to a $9 million positive impact of higher unit margins, partially offset by the impact of lower sales volumes of $4.2 million, higher operating expenses of $1.0 million and lower-of-cost-or-market adjustments of $1.7 million.

The decrease in Adjusted EBITDA of $10.0 million related to Other products reflects operating losses during the first half of fiscal 2009 for MTBE produced from crude C4 isobutylene, including a lower-of-cost-or-market adjustment of $4.9 million. Operating results related to MTBE business for the first half of fiscal 2008 relate only to MTBE produced from our Houston dehydrogenation units, for which historical results prior to December 31, 2007 are reported as a separate segment.

Liquidity and Capital Resources

At December 31, 2008 and June 30, 2008 we had cash on hand of $0.6 million. At December 31, 2008 we had outstanding borrowings of $46.5 million under our revolving credit facility, compared to $21.8 million at June 30, 2008.

Operating cash flows for the quarter and six months ended December 31, 2008 were negative $16.8 million and $11.9 million, respectively, reflecting negative income from operations for both periods. The negative operating cash flows for the second quarter reflect significant investment in working capital in October, as we recovered from the impact of the September hurricanes, and positive operating cash flows for both November and December. Our capital expenditures were $3.4 million and $11.2 million for the quarter and year-to-date, reflecting the completion of our major capital investment program in fiscal 2008 and tight control over spending in 2009 to conserve cash.

As of February 16, 2009, our current revolver borrowings were $23.9 million. Our borrowing base is currently $74.4 million. As a result, our borrowings under the revolving credit facility cannot exceed that amount less an availability block of $15.0 million. Available borrowings, together with cash flow from operations, provide us with sufficient liquidity to meet our anticipated working capital and operational requirements.

Conference Call

The Company has scheduled a conference call for 3:00 p.m. Eastern Time (2:00 p.m. Central) on Tuesday, February 17, 2009. To listen to the call, dial (303) 242-0001 at least 10 minutes prior to the start time and ask for the Texas Petrochemicals call, or access it live over the Internet by logging on to the Company’s website at http://www.txpetrochem.com. For those unable to listen to the live call, a replay will be available through Tuesday, March 3, 2009 by calling (303) 590-3000 using pass code 11126299#. Also, an archive of the webcast will be available shortly after the call on the Company’s website for approximately 90 days.

Headquartered in Houston, Texas, Texas Petrochemicals Inc. sells products into a wide range of performance, specialty and intermediate markets, including synthetic rubber, fuel additives, plastics and detergents. The Company has manufacturing facilities in the industrial corridor adjacent to the Houston Ship Channel, Port Neches and Baytown, Texas and operates a product terminal in Lake Charles, Louisiana. For more information, visit the Company’s web site at http://www.txpetrochem.com.

Cautionary Information Regarding Forward-Looking Statements

Certain oral and written information that the Company may make publicly available from time to time may constitute forward-looking statements. Such statements may relate to future operating results, existing and expected competition, financing and refinancing sources and availability, and plans related to strategic alternatives or future expansion activities and capital expenditures. Forward-looking statements involve a number of risks and uncertainties that may significantly affect the Company’s liquidity and results in the future and, accordingly, actual results may differ materially from those expressed in any forward-looking statements. Such risks and uncertainties include, but are not limited to, those related to effects of competition, leverage and debt service, financing and refinancing efforts, litigation and governmental investigations, environmental laws and regulations, general economic conditions and changes in laws or regulations.

    Investor Relations
    Contact: Robert Whitlow
    Email:   robert.whitlow@txpetrochem.com
    Phone:   713-627-7474

    Contact: Ruth Dreessen
    Email:   ruth.dreessen@txpetrochem.com
    Phone:   713-627-7474

    Media Relations
    Contact: Sara Cronin
    Email:   sara.cronin@txpetrochem.com
    Phone:   713-627-7474

- tables to follow -


                  texas petrochemicals, inc.
                 CONSOLIDATED BALANCE SHEETS
                       (in millions)

                                        December 31, June 30,
                                        ------------ --------
                                           2008        2008
                                           ----        ----
                                        (Unaudited)
                 ASSETS
    Current assets:
      Cash and cash equivalents             $0.6        $0.6
      Accounts receivable - trade           72.9       200.5
      Inventories                           44.6       102.5
      Other current assets                  26.2        28.5
                                            ----        ----

      Total current assets                 144.3       332.1

    Property, plant and equipment,
     net                                   536.2       546.0
    Investment in limited
     partnership                             3.0         2.4
    Intangible assets, net                   6.0         4.4
    Other assets, net                       21.9        20.4
                                            ----        ----

      Total assets                        $711.4      $905.3
                                          ======      ======

     LIABILITIES AND STOCKHOLDERS' EQUITY
    Current liabilities:
      Accounts payable - trade             $36.0      $218.6
      Accrued liabilities                   28.3        28.5
      Current portion of long-term
       debt                                  5.5         2.7
                                             ---         ---

      Total current liabilities             69.8       249.8

    Long-term debt                         317.7       294.4
    Deferred income taxes                   49.5        61.6
                                            ----        ----

      Total liabilities                    437.0       605.8

    Shareholders' equity                   274.4       299.5
                                           -----       -----

        Total liabilities and
         shareholders' equity             $711.4      $905.3
                                          ======      ======

                      Texas Petrochemicals, inc.
                Consolidated Statements of OperationS
           (Unaudited, in millions, except per share amounts)

                            Three Months Ended       Six Months Ended
                            ------------------       ----------------
                          September 30, December 31,    December 31,
                          -----------  ------------    ------------
                              2008    2008    2007    2008    2007
                              ----    ----    ----    ----    ----

    Revenues                 $543.3  $410.0  $509.9  $953.3  $996.0
    Cost of sales             471.9   375.7   450.0   847.5   869.3
                              -----   -----   -----   -----   -----
                               71.4    34.3    59.9   105.8   126.7
                               ----    ----    ----   -----   -----

    Operating expenses
      Operating
       expenses                35.8    31.7    31.2    67.5    60.2
      Selling,
       general and
       administrative
       expenses                 9.9    10.1     9.4    20.1    22.5
      Depreciation
       and
       amortization            10.0    10.6     8.9    20.7    16.5
      Loss on sale
       of assets                  -       -     1.1       -     1.1
      Lower-of-cost-
       or-market
       adjustment               9.4    11.6       -    21.0       -
      Unauthorized
       freight
       payments                   -       -       -       -     0.5
                               ----    ----    ----   -----   -----

                               65.1    64.0    50.6   129.3   100.8
                               ----    ----    ----   -----   -----

    Income (loss)
     from operations            6.3   (29.7)    9.3   (23.5)   25.9
                                ---   -----     ---   -----    ----

    Other (income) expense
      Interest
       expense                  4.1     5.2     5.5     9.3    10.7
      Interest income             -       -    (0.1)      -    (0.1)
      Unrealized
       loss on
       derivatives              0.4     5.0     1.0     5.3     1.1
      Other, net               (0.4)   (0.5)   (0.5)   (0.9)   (0.9)
                               ----    ----    ----    ----    ----

                                4.1     9.7     5.9    13.7    10.8

    Income (loss)
     before income
     taxes                      2.2   (39.4)    3.4   (37.2)   15.1

    Income tax
     (benefit)
     expense                    0.8   (12.7)    1.2   (11.9)    5.8
                                ---   -----     ---   -----     ---

    Net income (loss)          $1.4  $(26.7)   $2.2  $(25.3)   $9.3
                               ====  ======    ====  ======    ====

    Earnings (loss) per share:
      Basic                   $0.08  $(1.51)  $0.13  $(1.43)  $0.53
      Diluted                 $0.08  $(1.51)  $0.12  $(1.43)  $0.51

    Weighted average shares
     outstanding:
      Basic                    17.8    17.7    17.6    17.7    17.6
      Diluted                  18.2    17.7    18.1    17.7    18.1

                  TEXAS PETROCHEMICALS, INC.
           CONSOLIDATED STATEMENTS OF CASH FLOWS
                   (Unaudited, in millions)

                             Three Months    Six Months
                                 Ended          Ended
                             December 31,   December 31,
                             ------------   ------------
                              2008   2007    2008    2007
                              ----   ----    ----    ----

    Cash flows from
     operating activities:
      Net income (loss)     $(26.7)  $2.2  $(25.3)   $9.3
      Distributions
       received from joint
       venture                   -    0.3     0.2     0.5
      Adjustments to
       reconcile net income
       to net cash
       provided by operating
       activities:
        Depreciation and
         amortization         10.6    8.9    20.7    16.5
        Loss on sale of
         assets                  -    1.1       -     1.1
        Amortization of
         debt issuance
         costs                 0.3    0.3     0.6     0.6
        Pension expense        0.3    0.3     0.6     0.6
        Deferred income
         taxes               (12.0)  (4.4)  (12.0)   (0.5)
        Non-cash stock
         compensation
         expense               1.5    1.7     3.1     3.1
        Unrealized loss on
         derivatives           5.0    1.0     5.3     1.1
        Earnings from
         joint venture        (0.5)  (0.6)   (0.8)   (0.7)
        Change in assets
         and liabilities
          Accounts
           receivable         51.6   (3.9)  127.6   (17.0)
          Inventories        101.4   10.0    57.8    (8.8)
          Other assets         1.5   (1.3)   (0.9)   (5.9)
          Accounts payable
           and accrued
           liabilities      (149.8)  50.7  (188.8)   41.5
                            ------   ----  ------    ----
    Net cash provided by
     (used in) operating
     activities              (16.8)  66.3   (11.9)   41.4
                             -----   ----   -----    ----

    Cash flows from
     investing activities:
      Capital expenditures    (3.4) (28.0)  (11.2)  (40.0)
      Purchase of business
       assets                    -  (70.0)      -   (70.0)
                              ----  -----   -----   -----
    Net cash used in
     investing activities     (3.4) (98.0)  (11.2) (110.0)
                              ----  -----   -----  ------

    Cash flows from
     financing activities:
      Proceeds from term
       loan borrowings           -   70.0       -    70.0
      Repayments on term
       loans                  (0.7)  (0.7)   (1.4)   (1.2)
      Net proceeds from
       revolving credit
       facility borrowings    22.2  (24.7)   24.7       -
      Proceeds from
       insurance debt          0.2      -     5.9     6.4
      Payments on
       insurance debt         (1.6)  (1.8)   (3.1)   (3.4)
      Exercise of stock
       options                   -      -       -     0.2
      Repurchase of common
       stock                     -      -    (3.0)   (0.3)
                              ----   ----    ----    ----
    Net cash provided by
     financing activities     20.1   42.8    23.1    71.7
                              ----   ----    ----    ----

    Increase (decrease) in
     cash and cash
     equivalents              (0.1)  11.1    (0.0)    3.1

    Cash and cash
     equivalents, at
     beginning of period       0.7    1.5     0.6     9.5
                               ---    ---     ---     ---

    Cash and cash
     equivalents, at end of
     period                   $0.6  $12.6    $0.6   $12.6
                              ====  =====    ====   =====

                           TEXAS PETROCHEMICALS, INC.
                          BUSINESS SEGMENT INFORMATION
                            (Unaudited, in millions)

                               Three Months Ended         Six Months Ended
                               ------------------         ----------------
                            September 30, December 31,     December 31,
                            ------------ -------------     ------------
                                 2008    2008     2007     2008     2007
                                 ----    ----     ----     ----     ----

    Sales volumes (lbs):
    C4 Processing                499.9   548.8    791.1  1,048.7  1,545.8
    Performance Products         165.3   184.0    205.1    349.3    363.6
    MTBE (1)                         -       -     66.8        -    172.6
    Other (2)                     11.6    51.0        -     62.6        -
                                  ----    ----     ----     ----     ----

                                 676.8   783.8  1,063.0  1,460.6  2,082.0
                                 =====   =====  =======  =======  =======
    Revenues:
    C4 Processing               $405.4  $303.8   $371.5   $709.2   $724.6
    Performance Products         128.4    87.7    110.3    216.1    197.3
    MTBE (1)                         -       -     23.6        -     66.1
    Other (2)                      9.5    18.5      4.5     28.0      8.0
                                   ---    ----      ---     ----      ---

                                $543.3  $410.0   $509.9   $953.3   $996.0
                                ======  ======   ======   ======   ======
    Cost of sales (3):
    C4 Processing               $357.9  $286.3   $328.7   $644.2   $642.6
    Performance Products         104.4    70.0     91.4    174.3    160.6
    MTBE (1)                         -       -     25.8        -     59.2
    Other (2)                      9.6    19.4      4.1     29.0      6.9
                                   ---    ----      ---     ----      ---

                                $471.9  $375.7   $450.0   $847.5   $869.3
                                ======  ======   ======   ======   ======
    Adjusted EBITDA:
    C4 Processing                $16.0  $(13.4)   $19.9     $2.6    $37.7
    Performance Products          14.7     8.0     10.8     22.7     20.3
    MTBE (1)                         -       -     (2.7)       -      6.2
    Other (2)                     (5.5)   (4.7)    (0.2)   (10.1)    (0.1)
    Corporate                     (6.9)   (7.0)    (6.3)   (14.0)   (16.6)
                                  ----    ----     ----    -----    -----

                                 $18.3  $(17.1)   $21.5     $1.2    $47.5
                                 =====  ======    =====     ====    =====

    Notes to Business Segment Information
    [1] As reported in the above table, the "MTBE" segment represents MTBE
    produced by our Houston dehydrogenation units.  In conjunction with the
    start-up of our isobutylene processing unit in late first quarter of
    fiscal 2008, the dehydrogenation units were idled and all MTBE produced
    from those units was sold by the end of the second  quarter of fiscal
    2008.  Beginning with third quarter of fiscal 2008, MTBE production from
    crude C4 isobutylene was insignificant and  related revenues and operating
    results were included in the "Other" operating segment.

    [2] The "Other" segment includes MTBE production and sales beginning with
    third quarter of fiscal 2008.  Prior to the third quarter of fiscal 2008,
    the "Other" category included only production and sales of steam and
    excess electricity.

    [3] Excludes depreciation and amortization and operating expenses.

                            TEXAS PETROCHEMICALS, INC.
                  RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME
                             (Unaudited, in millions)

    This earnings release contains non-GAAP financial measures.  For purposes
    of Regulation G, a non-GAAP financial measure is a numerical measure of a
    company's historical or future financial performance, financial position
    or cash flows that excludes amounts, or is subject to adjustments that
    have the effect of excluding amounts, that are included in the most
    directly comparable measure calculated and presented in accordance with
    GAAP in the statements of operations, balance sheets, or statements of
    cash flows (or equivalent statements) of the Company; or includes amounts,
    or is subject to adjustments that have the effect of including amounts,
    that are excluded from the most directly comparable measure so calculated
    and presented.  In this regard GAAP refers to generally accepted
    accounting principles in the United States.  Pursuant to the requirements
    of Regulation G, the Company has provided below a reconciliation of the
    Adjusted EBITDA (non-GAAP financial measure) to net income (most directly
    comparable GAAP financial measure.

                                 Three Months Ended       Six Months Ended
                                 ------------------      -----------------
                               September 30, December 31,   December 31,
                               ------------- ------------   ------------
                                     2008    2008   2007    2008   2007
                                     ----    ----   ----    ----   ----
    Adjusted EBITDA:
     C4 processing                  $16.0  $(13.4) $19.9    $2.6  $37.7
     Performance products            14.7     8.0   10.8    22.7   20.3
     MTBE                               -       -   (2.7)      -    6.2
     Other                           (5.5)   (4.7)  (0.2)  (10.1)  (0.1)
     Corporate                       (6.9)   (7.0)  (6.3)  (14.0) (16.6)
    Reconciliation:
     Income tax (benefit)
      expense                        (0.8)   12.7   (1.2)   11.9   (5.8)
     Interest expense, net           (4.1)   (5.2)  (5.4)   (9.3) (10.6)
     Depreciation and
      amortization                  (10.0)  (10.6)  (8.9)  (20.7) (16.5)
     Loss on sale of assets             -       -   (1.1)      -   (1.1)
     Non-cash stock-based
      compensation                   (1.6)   (1.5)  (1.7)   (3.1)  (3.1)
     Unrealized loss on
      derivatives                    (0.4)   (5.0)  (1.0)   (5.3)  (1.1)
                                     ----    ----   ----    ----   ----

    Net income (loss)                $1.4  $(26.7)  $2.2  $(25.3)  $9.3
                                     ====  ======   ====  ======   ====

    EBITDA information is presented in this earnings release because
    management believes it enhances understanding by investors and lenders of
    the Company's financial performance.

SOURCE Texas Petrochemicals, Inc.


Source: newswire